Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results
April 18, 2024 06:00 ET
|
Biosplice Therapeutics, Inc.
Presentation of OA-07 Phase 3 Long-Term Results for Lorecivivint and Preliminary Analysis of OA-21 Trial 12-Week Pain Results
Global Osteoarthritis Therapeutics Market Analysis Report 2024-2030, by Drug (NSAIDs, Corticosteroids), Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), Sales Channel, End-use and Segment Forecasts
April 10, 2024 10:35 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report, Drug (NSAIDs, Corticosteroids), Anatomy (Knee Osteoarthritis, Hip...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA
April 08, 2024 06:30 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, April 08, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA
April 03, 2024 09:25 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, April 03, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA
April 03, 2024 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, April 03, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer
March 11, 2024 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, March 11, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of...
PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV
March 05, 2024 08:00 ET
|
PetVivo Holdings, Inc.
PetVivo Dual Lists on Upstream's Global Securities Trading App MINNEAPOLIS, MN, March 05, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging...
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California
February 29, 2024 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 29, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the...
PetVivo Holdings, Inc. Approved to Dual List on Upstream
February 27, 2024 08:00 ET
|
PetVivo Holdings, Inc.
Trading to begin on March 5, 2024 under “PETV”, all shareholders to receive commemorative NFT MINNEAPOLIS, Feb. 27, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW)...
ZKR Orthopedics Receives IDE Approval for Clinical Trial
February 14, 2024 08:47 ET
|
ZKR Orthopedics, Inc.
ZKR Orthopedics Receives IDE Approval for LIFT Implant Clinical Trial